Fear of Pain Clinical Trial
Official title:
The Effect of Virtual Reality and Ice Application on Fear of Self-injection and Self-test, Pain and State Anxiety Levels in Patients With Type 2 Diabetes
NCT number | NCT04436666 |
Other study ID # | seher cevik |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 15, 2020 |
Est. completion date | June 30, 2021 |
Verified date | December 2022 |
Source | Inonu University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
AİM:The aim of this study is to control the fears and anxieties of Type 2 diabetics in insulin injection and blood glucose measurement with motivational videos and Ice applications to be applied with virtual reality glasses. Material and Methods: The research is designed as a semi-experimental model with pretest-posttest control groups. The research will be carried out in the endocrine services located in Turgut Özal Medical Center in Malatya province. The universe of the research will be 2113 Type 2 diabetes patients who are being treated in the hospital specified on the specified dates, who are injecting insulin and following blood sugar. According to the analysis of the power, the sample of the research is composed of an experiment effect of 0.5% with bilateral significance level, 95% confidence interval determined with 5% error level, the experiment group to be applied with 80% Reality with 80% representation power, and the control group with 80 ice application. will create a total of 240 Type 2 diabetes patients.In the collection of the data, the Participant Presentation Form developed by the researcher, Diabetes Fear of Self Injecting and Self-testing Questionnaire-D-FISQ, State Anxiety Scale and VAS will be used.
Status | Completed |
Enrollment | 159 |
Est. completion date | June 30, 2021 |
Est. primary completion date | December 30, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Being literate, - Injecting insulin at least twice a day, - Following blood sugar at least twice a day, Exclusion Criteria: - Having any psychiatric diagnosis, - communication barriers - The patient has any diagnosis, such as epilepsy, that will trigger seizures. - Any diagnosis, such as vertigo, that causes dizziness in the patient. |
Country | Name | City | State |
---|---|---|---|
Turkey | seher ÇEVIK | Malatya |
Lead Sponsor | Collaborator |
---|---|
Inonu University |
Turkey,
Cevik S, Yagmur Y. Impact of intolerance of uncertainty on psychological well-being in pregnant women with or without miscarriage risk. Perspect Psychiatr Care. 2018 Jul;54(3):436-440. doi: 10.1111/ppc.12297. Epub 2018 May 25. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Injection fear reduction | (Diabetes Fear of Self Injecting and Self-testing Questionnaire-D-FISQ) D-FISQ was developed by Snoek et al. (1997) to measure the fear of self-injection and testing in individuals with diabetes who need insulin. D-FISQ with 15 expressions consists of two sub-dimensions, fear of self-injecting-FSI, 6 expressions, and fear of self-testing (FST, 9 expressions). Each statement has a 4-point Likert-type rating ranging from 1 to 4 (1 = almost never, 2 = sometimes, 3 = often, 4 = almost always). The evaluation of the inquiry form can be done by taking the average or raw score for the two sub-dimensions and the whole form. As the scores obtained from the scale increase, fear levels increase. Internal consistency coefficient of the scale is 0.96. | 1 month | |
Primary | anxiety reducation | State Anxiety Scale The scale, which was developed by Spielberger et al in 1970, was adapted to Turkish by Öner and LeCompte (1974). The emotions or behaviors expressed in the scale items are answered by marking one of the options such as (1) none, (2) a little, (3) a lot, and (4) completely. The scale containing twenty expressions contains 10 inverse (1, 2, 5, 8, 10, 11, 15, 16, 19, 20) expressions. While the reverse expressions expressing positive emotions are scored, those in one weight degree are converted into four, and those in four weight degrees into one. In the scoring, the total weighted score of the inverse statements is subtracted from the total weighted score and 50, an unchanged value, is added to this number. The total score value obtained from the scale can range from 20 to 80 points. A high score indicates that the level of anxiety is high. The total score value is evaluated as 20-39 mild anxiety, 40-59 moderate anxiety, and 60-79 severe anxiety. | 1 month | |
Primary | pain relief | (Visual Analogue Scale -VAS) This scale, which is used to measure subjectively perceived pain, was developed by Price et al. (1983), and has been used in many studies to evaluate the intensity of pain, it has been found to be reliable and valid. It is a 10 cm scale with "painlessness" on one end and "severe pain" on the other. Individuals participating in the study are asked to mark the level of pain severity they feel at the moment, explaining that the number "0" on the scale means that I do not feel any pain and the pain intensity increases as the numbers grow and the number "10" means the most severe pain. | 1 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04356352 -
Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT05109000 -
Comparison of Subcutaneous Injection of Normal Saline and Bacteriostatic Saline
|
Phase 4 | |
Completed |
NCT04582032 -
Effects of Cyclooxygenase (COX) 1-2 Inhibitors on Prevention of Rocuronium Injection Pain
|
N/A | |
Completed |
NCT02524743 -
The Prevention of Pain Associated With Rocuronium Injection
|
Phase 4 | |
Completed |
NCT04673500 -
Assessment of Pain on Propofol Injection.
|
N/A | |
Recruiting |
NCT05378113 -
Ondansetron as a Strategy for Reducing Propofol Injection Pain in Pediatrics: a Randomized Controlled Trial
|
Phase 2 | |
Completed |
NCT01824758 -
Effect of Esmolol on Pain Due to Rocuronium
|
Phase 4 | |
Completed |
NCT04555980 -
Warm Patch Decrease Propofol Injection Pain
|
N/A | |
Recruiting |
NCT03420560 -
A Warmer Temperature Decrease Propofol Injection Pain
|
N/A | |
Completed |
NCT05225610 -
Valsalva Manoeuvre and Intravenous Dexmedetomidine on Attenuating Pain During Propofol Injection in Upper GIT Endoscopy
|
N/A | |
Recruiting |
NCT05221333 -
Sorrel 25R Injector - Sorrel Clinical Study Protocol
|
N/A | |
Recruiting |
NCT05269823 -
Topical Ice-therapy for Intravitreal Injections
|
N/A |